ライフサイエンスコーパス: acetylsalicylic acid

1 nts with stable CAD taking low-dose aspirin (acetylsalicylic acid).

2 stoperative low-dose intravenous heparin and acetylsalicylic acid.

3 spirin was associated with lower exposure to acetylsalicylic acid (63% and 70% lower geometric mean m

4 r study, 34 blacks with stable CAD receiving acetylsalicylic acid 75 to 100 mg/d were randomized to c

5 ooxygenases in Drosophila and the failure of acetylsalicylic acid, a potent inhibitor of both COX-1 a

6 Acetylsalicylic acid, acetaminophen, atenolol, diclofena

7 adverse cardiovascular events compared with acetylsalicylic acid alone but increases the risk of ble

8 trategies) trial revealed that compared with acetylsalicylic acid alone, dual pathway inhibition with

9 ata from the Vascular Outcomes Study of ASA (acetylsalicylic acid) Along With Rivaroxaban in Endovasc

10 R PAD trial (Vascular Outcomes Study of ASA [Acetylsalicylic Acid] Along With Rivaroxaban in Endovasc

11 R PAD trial (Vascular Outcomes Study of ASA [Acetylsalicylic Acid] Along With Rivaroxaban in Endovasc

12 VOYAGER PAD (Vascular Outcomes Study of ASA [acetylsalicylic acid] Along with Rivaroxaban in Endovasc

13 Dual antiplatelet therapy (DAPT) with acetylsalicylic acid and a P2Y(12) inhibitor is an estab

14 ning the nonsteroidal anti-inflammatory drug acetylsalicylic acid and alanine as ligands (4).

15 eated with high doses of corticosteroids and acetylsalicylic acid and clinical conditions as well as

16 ervation that dual antiplatelet therapy with acetylsalicylic acid and clopidogrel was associated with

17 ebruary 2007) and the search term aspirin or acetylsalicylic acid and dose.

18 Indomethacin, acetylsalicylic acid and ibuprofen abolished the alterna

19 a minority of patients have a sensitivity to acetylsalicylic acid and other nonsteroidal anti-inflamm

20 ylated bovine serum albumin was inhibited by acetylsalicylic acid and sodium acetate as well as by N-

21 Aspirin (acetylsalicylic acid) and intravenous immunoglobulin (IV

22 Hypersensitivity reactions to aspirin (acetylsalicylic acid) and other nonsteroidal anti-inflam

23 ly to groups given 0.5 mug calcitriol, 75 mg acetylsalicylic acid, and 1250 mg calcium carbonate (n =

24 idine, loratadine, ibuprofen, acetaminophen, acetylsalicylic acid, and cocaine in various forms.

25 The Antiphospholipid Antibody Acetylsalicylic Acid (APLASA) study was a multicenter, r

26 Sodium salicylate and acetylsalicylic acid are drugs used as anti-inflammatory

27 nt platform formulation was used, containing acetylsalicylic acid as the Active Pharmaceutical Ingred

28 In blood from subjects receiving acetylsalicylic acid (ASA or aspirin), none of the measu

29 this study, we observed that pretreatment by acetylsalicylic acid (ASA) augmented TRAIL-induced apopt

30 Hypersensitivity to acetylsalicylic acid (ASA) constitutes a serious problem

31 by positive drug provocation test (DPT) with acetylsalicylic acid (ASA) during 2005-2012 (V1) were in

32 Discontinuation of low-dose acetylsalicylic acid (ASA) during the perioperative phas

33 e (PUD) in a cohort of new users of low-dose acetylsalicylic acid (ASA) for secondary prevention of c

34 The current study explored whether acetylsalicylic acid (ASA) had cytokine-repressing activ

35 Acetylsalicylic acid (ASA) may serve as a potential ther

36 agonist (VKA) monotherapy, 25,458 (35%) with acetylsalicylic acid (ASA) monotherapy and 8,962 (13%) w

37 glioma, treatment with the COX-2 inhibitors acetylsalicylic acid (ASA) or celecoxib inhibited system

38 In this study, we show that acetylsalicylic acid (ASA) treatment is able to signific

39 The effects of salicylic acid (SA) or acetylsalicylic acid (ASA) treatments during on-tree che

40 tudies investigating the association between acetylsalicylic acid (ASA) use and spontaneous subarachn

41 Bacillus velezensis, and the application of acetylsalicylic acid (ASA) via foliage application (FA),

42 The next day, sensitivity to acetylsalicylic acid (ASA) was proven in all patients wi

43 Morphine, MK-801 and acetylsalicylic acid (ASA) were active systemically in t

44 We aimed to evaluate whether the use of acetylsalicylic acid (ASA) would reduce the intensity of

45 2-0.79) among patients who received low-dose acetylsalicylic acid (ASA), 0.18 (95% CI, 0.04-0.79) for

46 euticals and personal care products (PPCPs) [acetylsalicylic acid (ASA), 2,5-dihydroxybenzoic acid (D

47 ry intervention (PCI) involves withdrawal of acetylsalicylic acid (ASA), or aspirin, while maintainin

48 In this study, we examined whether acetylsalicylic acid (ASA), so-called aspirin, enhances

49 Ps and 14-day CSPs) in healthy volunteers on acetylsalicylic acid (ASA).

50 nonsteroidal anti-inflammatory drugs such as acetylsalicylic acid (ASA).

51 -3 (Omega-3) polyunsaturated fatty acids and acetylsalicylic acid (ASA, aspirin) has shown better cli

52 ther targeting inflammation through low-dose acetylsalicylic acid (ASA, i.e., aspirin) is able to blu

53 olymorphism (PlA2) on platelet inhibition by acetylsalicylic acid (ASA, i.e., aspirin), clopidogrel,

54 l anticoagulant (DOAC) are using concomitant acetylsalicylic acid (ASA, or aspirin) and how this affe

55 Previous studies indicated that aspirin (acetylsalicylic acid [ASA]) can have profound immunomodu

56 the anti-inflammatory activities of aspirin (acetylsalicylic acid [ASA]) could protect against UVB-in

57 The inability of aspirin (acetylsalicylic acid [ASA]) to adequately suppress plate

58 n diabetic patients taking low-dose aspirin (acetylsalicylic acid, ASA), suggesting that such patient

59 ve substances such as paracetamol, caffeine, acetylsalicylic acid, aspartame, d-glucose, and detergen

60 igate the effect of three different doses of acetylsalicylic acid (aspirin) (ASA) on the late phase o

61 pment and characterization of hyperpolarized acetylsalicylic acid (aspirin) and its use as a nuclear

62 Acetylsalicylic acid (aspirin) and the naturally occurri

63 intensity ultrasound were investigated using acetylsalicylic acid (aspirin) crystals as a model compo

64 intestinal epithelia and when acetylated by acetylsalicylic acid (aspirin) initiates the biosynthesi

65 Acetylsalicylic acid (aspirin) is a cyclooxygenase (COX)

66 Although acetylsalicylic acid (aspirin) is commonly used for pati

67 Acetylsalicylic acid (aspirin) is highly effective for t

68 Acetylsalicylic acid (aspirin) is one of the most widely

69 Acetylsalicylic acid (aspirin) is the drug most commonly

70 Low-dose acetylsalicylic acid (aspirin) is widely used in the tre

71 gage items like detergent, sweetener, sugar, acetylsalicylic acid (aspirin), and paracetamol-caffeine

72 trial to determine whether a combination of acetylsalicylic acid (aspirin), calcitriol, and calcium

73 ing advanced neoplasms could be increased by acetylsalicylic acid (aspirin), especially among men.

74 een with nonselective COX inhibitors such as acetylsalicylic acid (aspirin).

75 Rivaroxaban 2.5 mg twice daily plus acetylsalicylic acid (aspirin; ASA) 100 mg reduced the r

76 ic human HNPCC tumor cell lines treated with acetylsalicylic acid (aspirin; ASA) and three isomeric d

77 The potential energy surface of acetylsalicylic acid, aspirin, has been explored at the

78 Low-dose acetylsalicylic acid at the time of bloodstream infectio

79 urred to varying degrees upon treatment with acetylsalicylic acid, benzoic acid, 2,4-dichlorophenoxya

80 azithromycin was significantly inhibited by acetylsalicylic acid but not by the other antipyretics.

81 uggest a direct antistaphylococcal effect of acetylsalicylic acid, but evidence from human studies is

82 umented as on antiplatelet therapy if taking acetylsalicylic acid, clopidogrel, and/or ticlopidine.

83 d to acetylsalicylic acid prophylaxis (80 mg acetylsalicylic acid daily for a 14-d period, starting 7

84 enge), acetylsalicylic acid treatment (80 mg acetylsalicylic acid daily for the 7-d period in-between

85 Furthermore, experience with acetylsalicylic acid desensitization in patients with CA

86 nted to determine the safety and efficacy of acetylsalicylic acid desensitization therapy in patients

87 national normalized ratio levels or those on acetylsalicylic acid had a decrease in risk of thrombosi

88 future DPT: for the rapid absorption group (acetylsalicylic acid, ibuprofen, ketoprofen, and tiaprof

89 rombin Inhibitor Dabigatran Etexilate Versus Acetylsalicylic Acid in Patients With Embolic Stroke of

90 anticoagulation, and even its replacement of acetylsalicylic acid in the presence of a P2Y(12) inhibi

91 Ex vivo exposure of platelets to acetylsalicylic acid increased production of tumor necro

92 patients receiving warfarin, adding aspirin (acetylsalicylic acid) increases bleeding risk with uncle

93 mation only after concomitant treatment with acetylsalicylic acid, indicating that defective glycopro

94 This acetylsalicylic acid-induced proinflammatory shift was a

95 Aspirin (acetylsalicylic acid) inhibits prostaglandin (PG) synthe

96 re required to investigate if early low-dose acetylsalicylic acid is a suitable treatment in patients

97 Although acetylsalicylic acid is of proven benefit for secondary

98 Regular use of aspirin (acetylsalicylic acid) is associated with reduced inciden

99 Aspirin (acetylsalicylic acid) is widely used for the acute treat

100 Low-dose acetylsalicylic acid (LDA) administered before 16 weeks'

101 iated with lower thrombotic event rates than acetylsalicylic acid monotherapy in patients with acute

102 idogrel is uniform for all patients or, like acetylsalicylic acid, more selective.

103 renal oximetry), prevention (statin therapy, acetylsalicylic acid, N-acetylcysteine, sodium bicarbona

104 Starting acetylsalicylic acid on the third day after surgery for

105 e influence of ibuprofen, acetaminophen, and acetylsalicylic acid on uptake, transport, and release o

106 s study, we analyzed the effects of aspirin (acetylsalicylic acid) on serine phosphorylation of insul

107 re randomly assigned (1:1) to receive 100 mg acetylsalicylic acid once per day in either the early-st

108 s reperfusion therapy, and were treated with acetylsalicylic acid, P2Y12 inhibitors, and statins to a

109 Reperfusion therapy, acetylsalicylic acid, P2Y12 inhibitors, and statins were

110 reatment, but not prophylaxis, with low-dose acetylsalicylic acid, partially reverses endotoxin toler

111 cytes of sepsis patients were incubated with acetylsalicylic acid preexposed platelets and were subse

112 Volunteers were randomized to acetylsalicylic acid prophylaxis (80 mg acetylsalicylic

113 Acetylsalicylic acid prophylaxis enhanced plasma tumor n

114 Aspirin (acetylsalicylic acid) prophylaxis suppresses major adver

115 Repeated oral administration of acetylsalicylic acid reduced all emissions.

116 ce-daily), an oral factor Xa inhibitor, plus acetylsalicylic acid reduced major adverse cardiovascula

117 clofibrate, di(2-ethylhexyl) phtalhate, and acetylsalicylic acid resulted in differential increases

118 increased risk was identified compared with acetylsalicylic acid (RR, 14.96; 95% CI, 0.85-262.00; 1

119 Most patients with acetylsalicylic acid sensitivity are able to undergo des

120 Acetylsalicylic acid sensitivity is common and desensiti

121 Patients taking aspirin (acetylsalicylic acid) showed mean blood loss of 43.26 +/

122 or peripheral vascular events than starting acetylsalicylic acid therapy at 30 days, with no increas

123 Whether early initiation of acetylsalicylic acid therapy is safe and improves clinic

124 After successful desensitization, acetylsalicylic acid therapy must be indefinitely contin

125 We aimed to estimate the effect of low-dose acetylsalicylic acid therapy on mortality in bloodstream

126 agents (e.g., statins), antiplatelet agents (acetylsalicylic acid, thienopyridines, thianopyridines,

127 patients with stable CAD receiving low-dose acetylsalicylic acid, ticagrelor provided a faster onset

128 Using the Apixaban versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrill

129 g 7 d before the first endotoxin challenge), acetylsalicylic acid treatment (80 mg acetylsalicylic ac

130 Acetylsalicylic acid treatment did not attenuate the dev

131 This proinflammatory phenotype in the acetylsalicylic acid treatment group was accompanied by

132 In contrast, acetylsalicylic acid treatment resulted in enhanced plas

133 mmunoparalysis might benefit from initiating acetylsalicylic acid treatment.

134 hich was strongly associated with a low-dose acetylsalicylic acid use (p < 0.001).

135 Low-dose acetylsalicylic acid use was associated with a reduced 3

136 In contrast, low-dose acetylsalicylic acid use was not associated with the pri

137 Age, sex, DBP, prior GI bleeding, prior acetylsalicylic acid use, and anemia were associated wit

138 tive pulmonary disease or GI bleeding, prior acetylsalicylic acid use, and anemia were independently

139 atients, respectively (1:1 match of low-dose acetylsalicylic acid users and nonusers).

140 l multicenter randomized controlled trial of acetylsalicylic acid versus warfarin for thromboprophyla

141 equivocal, and combinations of nitrates with acetylsalicylic acid were inactive.

142 ion, globe massage, and anticoagulation with acetylsalicylic acid were prescribed.

143 salicylate and salicylate precursors such as acetylsalicylic acid with certain other drugs.